Four years ago, Emily Whitehead, who was just seven years old at the time, inadvertently became headline news as her previously incurable acute lymphoblastic leukaemia (ALL) moved into remission an
The booming interest in new targeted therapies represents a changing of the guard in cancer treatment, from the former one-size-fits-all approach to a more personalised methodology.
